Podium Session 1: Kidney Cancer

Podium for the opposition?

This is quite a paradoxical era. Scientific research is in its most productive phase and it continues to produce many beneficial technologies for mankind. For example, we rapidly progress towards a better understanding of many diseases and come up with multiple new approaches to cure them. At the same time, however, the voices against science and technology have never been more shrill. But unsu...

First Day Session 1 : Opening Session

Reuse of experience and solutions for recurring development problems is of the utmost importance for a pragmatic software engineering discipline. The earlier in the development process reuse is achieved, the larger its positive impact on the project. This paper reports on reuse approaches that are applicable during the requirements analysis phase.

Session Wednesday January 21 st , 2015 Session 1 : 1 : 00 - 1 : 50 pm Session 2 : 1 : 50 - 2 : 45 pm

Session 6 : Cancer III

Antibodies endowed with binding specificity for peptide-major histocompatibility complexes (MHC) have broad application. We have designated monoclonal antibodies with T cell receptor(TCR) like binding specificity as TCRmimics. The MHC system binds peptides and presents them on the cell surface for T cell surveillance. Since peptides presented by MHC complexes reflect cellular status the MHC cla...

Session 7 : Cancer Applications

not provided. [14.50–15.10] ‘Ab targeted nanoparticles for cancer therapy’ Chris Scott The Queens University of Belfast, Northern Ireland Abstract not provided.not provided. [15.10–15.30] ‘Antibody-maytansinoid conjugates (AMCs) in the treatment of cancer: From promise to reality’ John M. Lambert ImmunoGen Inc., Waltham, Massachusetts, USA Early clinical development in the field of targeted del...